{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T17:28:20Z","timestamp":1787851700223,"version":"build-2784847793"},"reference-count":140,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ijbiomac.2026.153245","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T14:51:29Z","timestamp":1783090289000},"page":"153245","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Metabolic enzyme-based cancer therapy: Mechanisms, delivery strategies, and translational challenges"],"prefix":"10.1016","volume":"375","author":[{"given":"Mohammed","family":"Tarique","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2026.153245_bb0005","series-title":"World Cancer Rep.","author":"World Health Organization","year":"2024"},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.153245_bb0010","first-page":"210","article-title":"Enzymes as anticancer agents: emerging therapeutic alternatives","volume":"15","author":"Singh","year":"2019","journal-title":"J. Cancer Res. Ther."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.153245_bb0015","first-page":"145","article-title":"Targeting malfunctioning enzymes in disease","volume":"33","author":"Mishra","year":"2021","journal-title":"Biochem. Rev."},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.153245_bb0020","first-page":"1011","article-title":"Disadvantages of conventional drugs in cancer therapy","volume":"12","author":"Patel","year":"2018","journal-title":"Ther. Adv."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.153245_bb0025","first-page":"334","article-title":"Systemic toxicity and off-target effects of inhibitors","volume":"28","author":"Kumar","year":"2020","journal-title":"Pharmacol. Today."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.153245_bb0030","first-page":"12","article-title":"History of enzyme therapy: from pepsin to alteplase","volume":"45","author":"Williams","year":"2015","journal-title":"Mediev. Hist. J."},{"key":"10.1016\/j.ijbiomac.2026.153245_bb0035","series-title":"Approval of Recombinant Enzyme Drugs and Market Trends","author":"Food and Drug Administration","year":"2023"},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.153245_bb0040","first-page":"88","article-title":"Enzymes in the treatment of diverse diseases","volume":"19","author":"Anderson","year":"2022","journal-title":"Clin. Enzymol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.153245_bb0045","first-page":"77","article-title":"Approval of L-asparaginase for leukemia treatment","volume":"45","author":"Leventhal","year":"2021","journal-title":"Oncol. Rep."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.153245_bb0050","first-page":"201","article-title":"Mechanisms of L-asparaginase and amino acid-degrading enzymes","volume":"11","author":"Batool","year":"2016","journal-title":"Metab. Biol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.153245_bb0055","first-page":"45","article-title":"Recent advances in enzymes as therapeutic agents","volume":"22","author":"Gupta","year":"2024","journal-title":"Future Med."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.153245_bb0060","first-page":"912","article-title":"Roles of enzymes in various cancer types","volume":"114","author":"Lee","year":"2023","journal-title":"Cancer Sci."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.153245_bb0065","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.phytochem.2003.10.022","article-title":"Horseradish peroxidase: a modern view of a classic enzyme","volume":"65","author":"Veitch","year":"2004","journal-title":"Phytochemistry"},{"key":"10.1016\/j.ijbiomac.2026.153245_bb0070","article-title":"Mechanisms of HRP and GPX in maintaining cellular redox","volume":"52","author":"Bhamra","year":"2022","journal-title":"Redox Biol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.153245_bb0075","article-title":"Why abnormal HRP\/IAA levels affect melanoma cell viability","volume":"6","author":"Doskey","year":"2016","journal-title":"Sci. Rep."},{"issue":"18","key":"10.1016\/j.ijbiomac.2026.153245_bb0080","first-page":"6123","article-title":"Glutathione peroxidase levels in breast cancer cell lines","volume":"295","author":"Sun","year":"2020","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.153245_bb0085","first-page":"845","article-title":"Reduced enzymatic activity of GPX in tumor cells","volume":"10","author":"Zhang","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ijbiomac.2026.153245_bb0090","first-page":"118","article-title":"Targeting glutathione-linked antioxidative pathways","volume":"157","author":"Brigelius-Floh\u00e9","year":"2020","journal-title":"Free Radic. Biol. Med."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.153245_bb0095","article-title":"Glyco-engineered HRP in bladder carcinoma cells","volume":"37","author":"Babu","year":"2021","journal-title":"Biotechnol. Prog."},{"issue":"38","key":"10.1016\/j.ijbiomac.2026.153245_bb0100","doi-asserted-by":"crossref","first-page":"53222","DOI":"10.1021\/acsami.5c12967","article-title":"Dual-enzyme encapsulated porous nanocapsules for lysosome-targeted, hypoxia-amplified cancer therapy","volume":"17","author":"Bargakshatriya","year":"2025","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.153245_bb0105","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.biotechadv.2009.04.003","article-title":"Glucose oxidase - an overview","volume":"27","author":"Bankar","year":"2009","journal-title":"Biotechnol. Adv."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.153245_bb0110","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s00253-008-1407-4","article-title":"Glucose oxidase: natural occurrence, function and applications","volume":"78","author":"Wong","year":"2008","journal-title":"Appl. Microbiol. Biotechnol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.153245_bb0115","doi-asserted-by":"crossref","first-page":"6758","DOI":"10.1021\/nn401617u","article-title":"Glucose-responsive microgels for insulin delivery","volume":"7","author":"Gu","year":"2013","journal-title":"ACS Nano"},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.153245_bb0120","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1021\/cr068123a","article-title":"Electrochemical glucose biosensors","volume":"108","author":"Wang","year":"2008","journal-title":"Chem. Rev."},{"issue":"12","key":"10.1016\/j.ijbiomac.2026.153245_bb0125","first-page":"1611","article-title":"Glucose biosensors: an overview of use in clinical practice","volume":"6","author":"Yoo","year":"2006","journal-title":"Sensors"},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.153245_bb0130","article-title":"Glucose oxidase-based cancer starvation therapy","volume":"31","author":"Fu","year":"2019","journal-title":"Adv. Mater."},{"key":"10.1016\/j.ijbiomac.2026.153245_bb0135","first-page":"141","article-title":"Inhibition of tumor cell proliferation via gluconic acid and H2O2","volume":"161","author":"Zhang","year":"2018","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.153245_bb0140","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/s41467-017-00424-8","article-title":"Delivery strategies for GOx to tumor microenvironments","volume":"8","author":"Huo","year":"2017","journal-title":"Nat. Commun."},{"issue":"30","key":"10.1016\/j.ijbiomac.2026.153245_bb0145","first-page":"9632","article-title":"Hydroxyl radicals and cancer cell death triggered by GOx","volume":"140","author":"He","year":"2018","journal-title":"J. Am. Chem. Soc."},{"issue":"14","key":"10.1016\/j.ijbiomac.2026.153245_bb0150","first-page":"4274","article-title":"GOx-based multimodal therapeutic integration","volume":"46","author":"Fan","year":"2017","journal-title":"Chem. Soc. Rev."},{"issue":"14","key":"10.1016\/j.ijbiomac.2026.153245_bb0155","article-title":"Synergistic effects of GOx with immunotherapy","volume":"9","author":"Li","year":"2020","journal-title":"Adv. Healthc. Mater."},{"issue":"42","key":"10.1016\/j.ijbiomac.2026.153245_bb0160","article-title":"Fe3O4\/GOx-polypyrrole nanocomposites for breast cancer regression","volume":"13","author":"Zhou","year":"2017","journal-title":"Small"},{"issue":"33","key":"10.1016\/j.ijbiomac.2026.153245_bb0165","first-page":"11252","article-title":"GOx in tannic acid-coated frameworks","volume":"58","author":"Hao","year":"2019","journal-title":"Angew. Chem. Int. Ed."},{"issue":"16","key":"10.1016\/j.ijbiomac.2026.153245_bb0170","first-page":"4440","article-title":"GOx\/Zn2+ ZIF nanoparticles for HeLa tumor inhibition","volume":"10","author":"Zhang","year":"2019","journal-title":"Chem. Sci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.153245_bb0175","first-page":"143","article-title":"Synergistic nanosystems integrating GOx and carbon dots","volume":"12","author":"Zhang","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"12","key":"10.1016\/j.ijbiomac.2026.153245_bb0180","article-title":"GOx-melanin-MnO2 platforms for melanoma eradication","volume":"6","author":"Zhao","year":"2019","journal-title":"Adv. Sci."},{"issue":"2\u20133","key":"10.1016\/j.ijbiomac.2026.153245_bb0185","first-page":"67","article-title":"Asparaginase in childhood acute lymphoblastic leukemia","volume":"51","author":"Avramis","year":"2005","journal-title":"Chemotherapy"},{"issue":"4793","key":"10.1016\/j.ijbiomac.2026.153245_bb0190","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/1911114a0","article-title":"Evidence that the L-asparaginase activity of guinea pig serum is responsible for its antilymphoma effects","volume":"191","author":"Broome","year":"1961","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.153245_bb0195","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1084\/jem.98.6.565","article-title":"Regression of transplanted lymphomas in mice and rats","volume":"98","author":"Kidd","year":"1953","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.153245_bb0200","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/cncr.25489","article-title":"L-asparaginase treatment in ALL","volume":"117","author":"Pieters","year":"2011","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.153245_bb0205","first-page":"2411","article-title":"Intracellular Ca2+ release and caspase-3 activation","volume":"6","author":"Narta","year":"2007","journal-title":"Mol. Cancer Ther."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.153245_bb0210","first-page":"154","article-title":"Industrial-scale production of Aspergillus-derived asparaginase","volume":"7","author":"Chelf","year":"2021","journal-title":"Fermentation"},{"key":"10.1016\/j.ijbiomac.2026.153245_bb0215","first-page":"18","article-title":"Inhibition of mTOR pathway and protein synthesis","volume":"47","author":"Peng","year":"2016","journal-title":"Leuk. Res."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.153245_bb0220","first-page":"638","article-title":"Autophagy inhibition as a synergistic strategy in CML cells","volume":"7","author":"Wang","year":"2011","journal-title":"Autophagy"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.153245_bb0225","first-page":"140","article-title":"Role of chloroquine in enhancing asparaginase effect","volume":"117","author":"Han","year":"2011","journal-title":"Blood"},{"issue":"15","key":"10.1016\/j.ijbiomac.2026.153245_bb0230","article-title":"Dual targeting of asparagine metabolism and autophagy","volume":"35","author":"Takahashi","year":"2017","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.153245_bb0235","first-page":"127","article-title":"Induction of beclin-1 in ovarian cancer cells","volume":"124","author":"Yu","year":"2012","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.153245_bb0240","first-page":"211","article-title":"Versatility of asparaginase in glioblastoma","volume":"128","author":"Zhang","year":"2016","journal-title":"J. Neuro-Oncol."},{"issue":"14","key":"10.1016\/j.ijbiomac.2026.153245_bb0245","first-page":"3845","article-title":"Engineering strategies for asparaginase","volume":"10","author":"Krishnapriya","year":"2022","journal-title":"Biomater. Sci."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.153245_bb0250","first-page":"255","article-title":"Lipid-chitosan nanosystems for lung cancer inhibition","volume":"116","author":"Ueno","year":"1997","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ijbiomac.2026.153245_bb0255","first-page":"10","article-title":"PLGA encapsulation of asparaginase","volume":"211","author":"Wolfram","year":"2015","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.153245_bb0260","first-page":"187","article-title":"Reduced toxicity of PLGA-nanosystems","volume":"3","author":"Gasper","year":"2008","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ijbiomac.2026.153245_bb0265","first-page":"1056","article-title":"Chitosan\/beta-cyclodextrin nanocomposites","volume":"145","author":"Rahiminezhad","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.153245_bb0270","first-page":"321","article-title":"Arginine as a precursor for nitric oxide","volume":"39","author":"Delage","year":"2010","journal-title":"Amino Acids"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.153245_bb0275","first-page":"72","article-title":"The role of arginine in the urea cycle","volume":"12","author":"Wu","year":"2009","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"issue":"19","key":"10.1016\/j.ijbiomac.2026.153245_bb0280","first-page":"5643","article-title":"Arginine auxotrophy in melanoma","volume":"62","author":"Ensor","year":"2002","journal-title":"Cancer Res."},{"issue":"15","key":"10.1016\/j.ijbiomac.2026.153245_bb0285","article-title":"Antitumor effects of ADI","volume":"26","author":"Feun","year":"2008","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.153245_bb0290","first-page":"916","article-title":"History and sources of ADI","volume":"81","author":"Miyazaki","year":"1990","journal-title":"Jpn. J. Cancer Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.153245_bb0295","first-page":"138","article-title":"Suppression of angiogenesis by ADI","volume":"88","author":"Park","year":"2003","journal-title":"Br. J. Cancer"},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.153245_bb0300","first-page":"783","article-title":"Anti-angiogenic activity of ADI","volume":"5","author":"Beloussow","year":"2002","journal-title":"Mol. Ther."},{"issue":"10","key":"10.1016\/j.ijbiomac.2026.153245_bb0305","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1200\/JCO.2004.11.120","article-title":"Phase I clinical investigation of ADI-PEG20","volume":"22","author":"Izzo","year":"2004","journal-title":"J. Clin. Oncol."},{"issue":"14","key":"10.1016\/j.ijbiomac.2026.153245_bb0310","first-page":"3705","article-title":"Outcomes of ADI in lung cancer","volume":"19","author":"Ott","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ijbiomac.2026.153245_bb0315","series-title":"Phase I\/II study of pegylated arginine deiminase (ADI-PEG 20) in combination with gemcitabine and docetaxel in non-small cell and small cell lung cancers","author":"Auberle","year":"2024"},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.153245_bb0320","first-page":"125","article-title":"Synergy of ADI with chloroquine","volume":"17","author":"Kim","year":"2014","journal-title":"Prostate Cancer Prostatic Dis."},{"issue":"10","key":"10.1016\/j.ijbiomac.2026.153245_bb0325","first-page":"2135","article-title":"Recombinant human arginase-I in breast cancer","volume":"109","author":"Cheng","year":"2007","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.ijbiomac.2026.153245_bb0330","first-page":"753","article-title":"PEGylation and fusion protein design for arginase-I","volume":"16","author":"Tsui","year":"2009","journal-title":"Cancer Gene Ther."},{"issue":"10","key":"10.1016\/j.ijbiomac.2026.153245_bb0335","first-page":"4003","article-title":"Limitations of human source purification","volume":"9","author":"Cellarier","year":"2003","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.153245_bb0340","first-page":"112","article-title":"Arginine decarboxylase: toxicity and agmatine metabolism","volume":"126","author":"Mistry","year":"2012","journal-title":"Toxicol. Sci."},{"issue":"11\u221212","key":"10.1016\/j.ijbiomac.2026.153245_bb0345","first-page":"830","article-title":"Methionine as a precursor for glutathione","volume":"23","author":"Lu","year":"2007","journal-title":"Nutrition"},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2026.153245_bb0350","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0304-419X(84)90019-2","article-title":"Impact of methionine depletion on epigenetic regulation","volume":"738","author":"Hoffman","year":"1984","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"21","key":"10.1016\/j.ijbiomac.2026.153245_bb0355","first-page":"4809","article-title":"Disruption of methylation by methionase","volume":"57","author":"Kokkinakis","year":"1997","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.ijbiomac.2026.153245_bb0360","first-page":"3097","article-title":"Cell cycle arrest via methionine depletion","volume":"59","author":"Tan","year":"1999","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.ijbiomac.2026.153245_bb0365","first-page":"2583","article-title":"Pseudomonas putida recombinant methionase","volume":"58","author":"Yoshioka","year":"1998","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.ijbiomac.2026.153245_bb0370","first-page":"2831","article-title":"Phase I clinical trials of PEGylated methionase","volume":"14","author":"Tan","year":"1996","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.153245_bb0375","doi-asserted-by":"crossref","first-page":"27715","DOI":"10.1038\/s41598-024-78368-5","article-title":"Aspergillus flavipes L-methionine \u03b3-lyase-\u03b2-cyclodextrin conjugates with improved stability, catalytic efficiency and anticancer activity","volume":"14","author":"El-Sayed","year":"2024","journal-title":"Sci. Rep."},{"issue":"15","key":"10.1016\/j.ijbiomac.2026.153245_bb0380","first-page":"3121","article-title":"Minimal toxicity of methionase","volume":"57","author":"Tan","year":"1997","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.ijbiomac.2026.153245_bb0385","first-page":"2253","article-title":"Role of lysine in protein acetylation","volume":"427","author":"Fothergill","year":"2015","journal-title":"J. Mol. Biol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.153245_bb0390","first-page":"387","article-title":"Anticancer activity of lysine oxidase","volume":"44","author":"Kusakabe","year":"1980","journal-title":"Agric. Biol. Chem."},{"issue":"15","key":"10.1016\/j.ijbiomac.2026.153245_bb0395","first-page":"6142","article-title":"Tumor-promoting effects of lysyl oxidase","volume":"5","author":"Moon","year":"2014","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.153245_bb0400","first-page":"600","article-title":"Glutamine and cancer","volume":"218","author":"Souba","year":"1993","journal-title":"Ann. Surg."},{"issue":"5541","key":"10.1016\/j.ijbiomac.2026.153245_bb0405","first-page":"321","article-title":"Cytotoxicity of Achromobacter glutaminase","volume":"259","author":"Roberts","year":"1976","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.153245_bb0410","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1042\/bj3480257","article-title":"Enhanced apoptosis via glutamine deprivation","volume":"348","author":"Lobo","year":"2000","journal-title":"Biochem. J."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.153245_bb0415","first-page":"236","article-title":"Context-dependent effects of glutaminase","volume":"35","author":"Medina","year":"2014","journal-title":"Trends Pharmacol. Sci."},{"issue":"36","key":"10.1016\/j.ijbiomac.2026.153245_bb0420","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1038\/s41388-025-03495-w","article-title":"Glutaminase as a metabolic target of choice to counter acquired resistance to Palbociclib by colorectal cancer cells","volume":"44","author":"Tarrado-Castellarnau","year":"2025","journal-title":"Oncogene"},{"key":"10.1016\/j.ijbiomac.2026.153245_bb0425","unstructured":"Sarkissian, C. N., et al. (2001). Phenylalanine as a precursor for tyrosine. Mol. Genet. Metab., 74(1\u20132), 173\u2013182."},{"key":"10.1016\/j.ijbiomac.2026.153245_bb0430","first-page":"111","article-title":"Micelle encapsulation of PAL","volume":"203","author":"Kim","year":"2015","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.153245_bb0435","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s13205-023-03871-x","article-title":"Agricultural wastes: a new promising source for phenylalanine ammonia-lyase as anticancer agent","volume":"14","author":"Albogami","year":"2024","journal-title":"3 Biotech"},{"key":"10.1016\/j.ijbiomac.2026.153245_bb0440","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jconrel.2024.01.041","article-title":"A biomimetic nanocarrier facilitates glucose consumption and reactive oxide species accumulation in enzyme therapy for colorectal cancer","volume":"367","author":"Peng","year":"2024","journal-title":"J. Control. Release"},{"issue":"23","key":"10.1016\/j.ijbiomac.2026.153245_bb0445","doi-asserted-by":"crossref","DOI":"10.3390\/polym16233260","article-title":"Enhancing the stability and anticancer activity of Escherichia coli asparaginase through nanoparticle immobilization: a biotechnological perspective on nano chitosan","volume":"16","author":"Alharthi","year":"2024","journal-title":"Polymers"},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.153245_bb0450","doi-asserted-by":"crossref","first-page":"175","DOI":"10.55544\/jrasb.2.6.26","article-title":"Targeted therapies in cancer treatment: unveiling the latest breakthroughs and promising approaches","volume":"2","author":"Rai","year":"2024","journal-title":"Journal for Research in Applied Sciences and Biotechnology"},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.153245_bb0455","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1039\/D4NA00924J","article-title":"Emerging engineered nanozymes: current status and future perspectives in cancer treatments","volume":"7","author":"Zheng","year":"2025","journal-title":"Nanoscale Adv."},{"key":"10.1016\/j.ijbiomac.2026.153245_bb0460","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2025.124668","article-title":"Carboxymethyl chitosan-based injectable hydrogel immobilizing single-atom nanozymes for localized ROS amplification and ferroptosis-enhanced postoperative oral cancer therapy","volume":"373","author":"Qi","year":"2026","journal-title":"Carbohydr. Polym."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.153245_bb0465","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1186\/s12951-024-02859-w","article-title":"Redox-manipulating nanocarriers for anticancer drug delivery: a systematic review","volume":"22","author":"Meng","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.ijbiomac.2026.153245_bb0470","article-title":"Selective enhanced cytotoxicity of amino acid deprivation for cancer therapy using thermozyme functionalized nanocatalyst","volume":"373","author":"Tang","year":"2026","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.ijbiomac.2026.153245_bb0475","first-page":"5123","article-title":"GOx delivery in prostate cancer","volume":"9","author":"Cunha-Junior","year":"2016","journal-title":"Onco. Targets Ther."},{"key":"10.1016\/j.ijbiomac.2026.153245_bb0480","doi-asserted-by":"crossref","first-page":"12358","DOI":"10.1021\/acsnano.3c01599","article-title":"Remote activation of enzyme nanohybrids for cancer prodrug therapy controlled by magnetic heating","volume":"17","author":"Torres-Herrero","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.ijbiomac.2026.153245_bb0485","doi-asserted-by":"crossref","DOI":"10.3390\/polym9070255","article-title":"Glucose oxidase-based glucose-sensitive drug delivery for diabetes treatment","volume":"9","author":"Zhao","year":"2017","journal-title":"Polymers"},{"key":"10.1016\/j.ijbiomac.2026.153245_bb0490","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201805919","article-title":"Nanocatalysts-augmented and photothermal-enhanced tumor-specific sequential nanocatalytic therapy in both NIR-I and NIR-II biowindows","volume":"31","author":"Feng","year":"2019","journal-title":"Adv. Mater."},{"key":"10.1016\/j.ijbiomac.2026.153245_bb0495","doi-asserted-by":"crossref","first-page":"7609","DOI":"10.1021\/acs.nanolett.8b03178","article-title":"An adenosine triphosphate-responsive autocatalytic Fenton nanoparticle for tumor ablation with self-supplied H 2 O 2 and acceleration of Fe(III)\/Fe(II) conversion","volume":"18","author":"Zhang","year":"2018","journal-title":"Nano Lett."},{"key":"10.1016\/j.ijbiomac.2026.153245_bb0500","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101274","article-title":"Tumor microenvironment-activated degradable multifunctional nanoreactor for synergistic cancer therapy and glucose SERS feedback","volume":"23","author":"Sun","year":"2020","journal-title":"iScience"},{"key":"10.1016\/j.ijbiomac.2026.153245_bb0505","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120106","article-title":"Biodegradable poly(\u03b3-glutamic acid)@glucose oxidase@carbon dot nanoparticles for simultaneous multimodal imaging and synergetic cancer therapy","volume":"252","author":"Zhang","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijbiomac.2026.153245_bb0510","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.2147\/IJN.S195900","article-title":"Glucose-responsive mesoporous silica nanoparticles to generation of hydrogen peroxide for synergistic cancer starvation and chemistry therapy","volume":"14","author":"Du","year":"2019","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ijbiomac.2026.153245_bb0515","doi-asserted-by":"crossref","DOI":"10.1002\/mabi.201900183","article-title":"Intracellular delivery of glucose oxidase for enhanced cytotoxicity toward PSMA-expressing prostate cancer cells","volume":"19","author":"Flynn","year":"2019","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.ijbiomac.2026.153245_bb0520","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.colsurfb.2016.03.046","article-title":"Chitosan-modified lipid nanovesicles for efficient systemic delivery of l-asparaginase","volume":"143","author":"Wan","year":"2016","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.ijbiomac.2026.153245_bb0525","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2019.101417","article-title":"Synthesis, characterization and anticancer activity of \u03b2-cyclodextrin-Asparaginase nanobiocomposite on prostate and lymphoma cancer cells","volume":"55","author":"Baskar","year":"2020","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"10.1016\/j.ijbiomac.2026.153245_bb0530","doi-asserted-by":"crossref","first-page":"15394","DOI":"10.1016\/j.jmrt.2020.10.021","article-title":"Immobilization of l-asparaginase on gold nanoparticles for novel drug delivery approach as anti-cancer agent against human breast carcinoma cells","volume":"9","author":"Al-Dulimi","year":"2020","journal-title":"J. Mater. Res. Technol."},{"key":"10.1016\/j.ijbiomac.2026.153245_bb0535","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/3534807","article-title":"Nanoliposomal L-asparaginase and its antitumor activities in Lewis lung carcinoma tumor-induced BALB\/c mice","volume":"2019","author":"Do","year":"2019","journal-title":"Adv. Mater. Sci. Eng."},{"key":"10.1016\/j.ijbiomac.2026.153245_bb0540","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.jddst.2018.02.007","article-title":"Gold nanoparticle mediated delivery of fungal asparaginase against cancer cells","volume":"44","author":"Baskar","year":"2018","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"10.1016\/j.ijbiomac.2026.153245_bb0545","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.msec.2018.08.051","article-title":"Synthesis, characterization and synergistic activity of cerium-selenium nanobiocomposite of fungal l-asparaginase against lung cancer","volume":"93","author":"Baskar","year":"2018","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"key":"10.1016\/j.ijbiomac.2026.153245_bb0550","doi-asserted-by":"crossref","first-page":"24030","DOI":"10.1039\/D0NR06823C","article-title":"Selective extracellular arginine deprivation by a single injection of cellular non-uptake arginine deiminase nanocapsules for sustained tumor inhibition","volume":"12","author":"Qi","year":"2020","journal-title":"Nanoscale"},{"key":"10.1016\/j.ijbiomac.2026.153245_bb0555","first-page":"619","article-title":"Preparation, characterization and pharmacokinetic study of arginine deiminase lipid nanoparticles","volume":"52","author":"Zhong","year":"2021","journal-title":"Sichuan Da Xue Xue Bao Yi Xue Ban"},{"key":"10.1016\/j.ijbiomac.2026.153245_bb0560","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1339580","article-title":"The application of peroxidase mimetic nanozymes in cancer diagnosis and therapy","volume":"15","author":"Moradi Hasan-Abad","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2026.153245_bb0565","doi-asserted-by":"crossref","DOI":"10.3390\/app13169382","article-title":"Cytotoxic effect of L-methioninase from Brevibacterium linens BL2 in combination with etoposide against glioblastoma cells","volume":"13","author":"\u0130pek","year":"2023","journal-title":"Appl. Sci."},{"key":"10.1016\/j.ijbiomac.2026.153245_bb0570","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14050927","article-title":"Monoclonal antibody functionalized, and L-lysine \u03b1-oxidase loaded PEGylated-chitosan nanoparticle for HER2\/Neu targeted breast cancer therapy","volume":"14","author":"Saravanakumar","year":"2022","journal-title":"Pharmaceutics"},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.153245_bb0575","first-page":"727","article-title":"Zinc oxide nanoparticles-glutaminase conjugates as promising anti- A-549 cells (lung carcinoma)","volume":"65","author":"Elhateir","year":"2022","journal-title":"Egypt. J. Chem."},{"issue":"10","key":"10.1016\/j.ijbiomac.2026.153245_bb0580","first-page":"9123","article-title":"AuNPs and peroxidase nanoconjugates","volume":"10","author":"Zheng","year":"2016","journal-title":"ACS Nano"},{"key":"10.1016\/j.ijbiomac.2026.153245_bb0585","first-page":"110","article-title":"Nanohybrids for pancreatic cancer","volume":"124","author":"Xie","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijbiomac.2026.153245_bb0590","first-page":"312","article-title":"Silica NPs with PLL\/HA modification","volume":"91","author":"Liu","year":"2018","journal-title":"Mater. Sci. Eng. C: C"},{"key":"10.1016\/j.ijbiomac.2026.153245_bb0595","first-page":"112","article-title":"Asprgd on AuNPs","volume":"235","author":"Al-Ahmady","year":"2016","journal-title":"J. Control. Release"},{"issue":"43","key":"10.1016\/j.ijbiomac.2026.153245_bb0600","doi-asserted-by":"crossref","first-page":"36441","DOI":"10.1039\/D5RA05472A","article-title":"Medicinal chemistry perspectives on anticancer drug design based on clinical applications (2015-2025)","volume":"15","author":"Al-Karmalawy","year":"2025","journal-title":"RSC Adv."},{"issue":"12","key":"10.1016\/j.ijbiomac.2026.153245_bb0605","first-page":"4567","article-title":"DSPE\/PEG200 liposomes","volume":"101","author":"Gasper","year":"2012","journal-title":"J. Pharm. Sci."},{"issue":"28","key":"10.1016\/j.ijbiomac.2026.153245_bb0610","first-page":"7012","article-title":"AuNP-Asp composites","volume":"34","author":"Min","year":"2013","journal-title":"Biomaterials"},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.153245_bb0615","first-page":"2231","article-title":"Potentiated ROS via asparaginase and cerium-selenium NPs","volume":"37","author":"Zhang","year":"2015","journal-title":"Biotechnol. Lett."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.153245_bb0620","first-page":"543","article-title":"Phosphorylcholine nanocapsules for ADI release","volume":"35","author":"Gao","year":"2014","journal-title":"Biomaterials"},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.153245_bb0625","first-page":"392","article-title":"Red blood cell-encapsulated L-asparaginase: potential therapy of patients with asparagine synthetase deficient acute myeloid leukemia","volume":"20","author":"Agrawal","year":"2013","journal-title":"Protein Pept. Lett."},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.153245_bb0630","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1080\/17425247.2023.2219890","article-title":"Preclinical and clinical developments in enzyme-loaded red blood cells: an update","volume":"20","author":"Bianchi","year":"2023","journal-title":"Expert Opin. Drug Deliv."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.153245_bb0635","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1021\/acsomega.1c05558","article-title":"Characteristics and stability assessment of therapeutic methionine \u03b3-lyase-loaded polyionic vesicles","volume":"7","author":"Koval","year":"2021","journal-title":"ACS Omega"},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.153245_bb0640","first-page":"815","article-title":"ADI lipid NPs","volume":"24","author":"Li","year":"2016","journal-title":"J. Drug Target."},{"issue":"12","key":"10.1016\/j.ijbiomac.2026.153245_bb0645","first-page":"9451","article-title":"Synergistic methionase and etoposide","volume":"36","author":"Yao","year":"2015","journal-title":"Tumour Biol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.153245_bb0650","first-page":"523","article-title":"PEGylated chitosan NPs","volume":"13","author":"Zhu","year":"2017","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ijbiomac.2026.153245_bb0655","first-page":"1022","article-title":"ZnO NPs and glutaminase","volume":"334","author":"Wang","year":"2018","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.ijbiomac.2026.153245_bb0660","first-page":"1","article-title":"Strategies for overcoming proteolytic degradation","volume":"28","author":"Parodi","year":"2014","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2026.153245_bb0665","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.nbt.2024.07.001","article-title":"Targeted HER2-positive cancer therapy using ADAPT6 fused to horseradish peroxidase","volume":"83","author":"Wisniewski","year":"2024","journal-title":"New Biotechnol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.153245_bb0670","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13036-024-00418-3","article-title":"Enhanced therapeutic potential of antibody fragment via IEDDA-mediated site-specific albumin conjugation","volume":"18","author":"Go","year":"2024","journal-title":"J. Biol. Eng."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.153245_bb0675","first-page":"229","article-title":"Improving the therapeutic index of enzymes","volume":"5","author":"Torchilin","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.153245_bb0680","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s40259-023-00622-5","article-title":"Enzyme engineering strategies for the bioenhancement of L-asparaginase used as a biopharmaceutical","volume":"37","author":"Miranda","year":"2023","journal-title":"BioDrugs"},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.153245_bb0685","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1002\/humu.23545","article-title":"Mutations and common variants in the human arginase 1 (ARG1) gene: impact on patients, diagnostics, and protein structure considerations","volume":"39","author":"Diez-Fernandez","year":"2018","journal-title":"Hum. Mutat."},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.153245_bb0690","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1021\/cbe.5c00002","article-title":"Combing directed enzyme evolution with metabolic engineering to develop efficient microbial cell factories","volume":"2","author":"Ren","year":"2025","journal-title":"Chem. Bio. Eng."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.153245_bb0695","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nrd1033","article-title":"Effect of PEGylation on pharmaceuticals","volume":"2","author":"Harris","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijbiomac.2026.153245_bb0700","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.122920","article-title":"Combinatorial therapeutic enzymes to combat multidrug resistance in bacteria","volume":"353","author":"Upadhyay","year":"2024","journal-title":"Life Sci."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026031855?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026031855?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T17:06:34Z","timestamp":1787850394000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813026031855"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":140,"alternative-id":["S0141813026031855"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.153245","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic enzyme-based cancer therapy: Mechanisms, delivery strategies, and translational challenges","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.153245","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"153245"}}